###################################################################################################################################################################
#Enrichment results using 'Molecular Function from Gene Ontology (GO)', created by dcGO Enrichment at 16/06/2016 14:19:38 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0004872	receptor activity	1	4.93	7.12e-06	1.07e-04	37|284|174|2762	PF00020;PF00040;PF00041;PF00057;PF00059;PF00090;PF00106;PF00130;PF00754;PF00757;PF00969;PF00989;PF01030;PF01033;PF01064;PF01179;PF01391;PF01392;PF01403;PF01437;PF01833;PF02140;PF02210;PF02225;PF02518;PF02931;PF04389;PF07645;PF07647;PF07654;PF07679;PF07686;PF08246;PF08447;PF08515;PF13426;PF13855
Group	GO:0060089	molecular transducer activity	1	3.97	2.03e-04	1.70e-03	33|284|172|2762	PF00020;PF00041;PF00057;PF00059;PF00090;PF00106;PF00130;PF00754;PF00757;PF00780;PF00969;PF00989;PF01030;PF01064;PF01392;PF01403;PF01437;PF01833;PF02140;PF02518;PF02865;PF02931;PF03165;PF07645;PF07647;PF07654;PF07679;PF07686;PF08246;PF08447;PF08515;PF13426;PF13855
Group	GO:0008092	cytoskeletal protein binding	1	3.67	5.42e-04	3.07e-03	30|284|159|2762	PF00041;PF00063;PF00169;PF00241;PF00307;PF00373;PF00400;PF00435;PF00611;PF00651;PF01044;PF01302;PF02181;PF03133;PF06367;PF06371;PF07651;PF07679;PF07707;PF08736;PF08926;PF09379;PF09380;PF10409;PF12510;PF12796;PF13385;PF13405;PF13637;PF13733
Group	GO:0060589	nucleoside-triphosphatase regulator activity	2	8.49	1.40e-11	1.35e-09	28|284|68|2762	PF00027;PF00063;PF00130;PF00168;PF00169;PF00226;PF00307;PF00373;PF00415;PF00435;PF00611;PF00618;PF00780;PF01369;PF01412;PF02141;PF02145;PF02185;PF02204;PF03455;PF06920;PF07647;PF07653;PF09324;PF11971;PF12783;PF13716;PF14429
Group	GO:0019904	protein domain specific binding	2	8.33	1.53e-11	1.35e-09	31|284|82|2762	PF00041;PF00076;PF00122;PF00169;PF00373;PF00400;PF00452;PF00564;PF00689;PF00690;PF00702;PF00757;PF00778;PF01030;PF01392;PF01562;PF02518;PF02828;PF06741;PF07647;PF07653;PF07679;PF07686;PF08232;PF08736;PF09379;PF09380;PF10409;PF10600;PF10608;PF12796
Group	GO:0032403	protein complex binding	2	7.40	1.70e-09	9.97e-08	26|284|71|2762	PF00041;PF00049;PF00053;PF00090;PF00093;PF00094;PF00169;PF00240;PF00307;PF00373;PF00435;PF01064;PF01179;PF01391;PF01421;PF01562;PF01753;PF01826;PF03921;PF07645;PF07653;PF07679;PF08232;PF08515;PF08742;PF09289
Group	GO:0051020	GTPase binding	2	6.76	1.00e-07	4.40e-06	17|284|40|2762	PF00130;PF00169;PF00307;PF00515;PF00611;PF00618;PF02181;PF02185;PF02204;PF02214;PF02759;PF03810;PF06367;PF06371;PF06920;PF12796;PF14429
Group	GO:0035639	purine ribonucleoside triphosphate binding	2	6.07	1.51e-07	5.33e-06	31|284|114|2762	PF00063;PF00122;PF00130;PF00270;PF00271;PF00289;PF00349;PF00350;PF00385;PF00586;PF00675;PF00689;PF00690;PF00702;PF00780;PF01064;PF01751;PF01841;PF01909;PF02263;PF02518;PF02769;PF02824;PF03810;PF03953;PF05193;PF06733;PF08515;PF08926;PF13086;PF13589
Group	GO:0032555	purine ribonucleotide binding	2	5.86	2.86e-07	8.39e-06	33|284|129|2762	PF00027;PF00063;PF00122;PF00130;PF00270;PF00271;PF00289;PF00349;PF00350;PF00385;PF00501;PF00586;PF00675;PF00689;PF00690;PF00702;PF00780;PF01064;PF01751;PF01841;PF01909;PF02263;PF02518;PF02769;PF02824;PF03810;PF03953;PF05193;PF06733;PF08515;PF08926;PF13086;PF13589
Group	GO:0005102	receptor binding	2	5.47	7.77e-07	1.95e-05	41|284|186|2762	PF00019;PF00041;PF00049;PF00053;PF00059;PF00090;PF00093;PF00094;PF00130;PF00168;PF00169;PF00270;PF00271;PF00307;PF00373;PF00400;PF00435;PF00515;PF00688;PF00989;PF01391;PF01392;PF01403;PF01421;PF01437;PF01562;PF01826;PF02210;PF02377;PF03921;PF07645;PF07653;PF07679;PF07686;PF08447;PF08742;PF10600;PF10608;PF12697;PF12796;PF13855
Group	GO:0030554	adenyl nucleotide binding	2	5.45	2.22e-06	4.88e-05	26|284|97|2762	PF00027;PF00063;PF00122;PF00130;PF00271;PF00289;PF00349;PF00385;PF00501;PF00586;PF00675;PF00689;PF00690;PF00702;PF00780;PF01064;PF01751;PF01909;PF02518;PF02769;PF05193;PF06733;PF08515;PF08926;PF13086;PF13589
Group	GO:0019199	transmembrane receptor protein kinase activity	2	5.99	2.63e-06	5.13e-05	13|284|30|2762	PF00041;PF00754;PF00757;PF01030;PF01064;PF01392;PF01403;PF07645;PF07647;PF07679;PF07686;PF08515;PF13855
Group	GO:0005509	calcium ion binding	2	5.44	5.49e-06	9.66e-05	18|284|56|2762	PF00059;PF00086;PF00122;PF00149;PF00153;PF00168;PF00683;PF00689;PF00690;PF00702;PF00754;PF01421;PF01477;PF02210;PF07645;PF07647;PF08487;PF13405
Group	GO:0019900	kinase binding	2	5.35	7.28e-06	1.07e-04	18|284|57|2762	PF00027;PF00041;PF00169;PF00307;PF00400;PF00415;PF00564;PF00778;PF01562;PF02210;PF02518;PF02865;PF07653;PF09058;PF10600;PF10608;PF11934;PF12796
Group	GO:0004713	protein tyrosine kinase activity	2	5.54	9.43e-06	1.28e-04	13|284|33|2762	PF00041;PF00169;PF00373;PF00611;PF00754;PF00757;PF01030;PF01392;PF01403;PF01833;PF07647;PF07679;PF07686
Group	GO:0008289	lipid binding	2	4.82	1.98e-05	2.32e-04	25|284|102|2762	PF00053;PF00054;PF00063;PF00130;PF00149;PF00168;PF00169;PF00373;PF00400;PF00435;PF00452;PF00564;PF00611;PF00622;PF00754;PF01302;PF01369;PF01412;PF02141;PF03455;PF03765;PF07651;PF07654;PF12796;PF13716
Group	GO:0008047	enzyme activator activity	2	4.74	5.03e-05	4.92e-04	17|284|59|2762	PF00019;PF00045;PF00063;PF00085;PF00086;PF00168;PF00226;PF00400;PF00413;PF00611;PF00688;PF01412;PF01471;PF02145;PF07647;PF08246;PF12763
Group	GO:0046914	transition metal ion binding	2	4.33	6.69e-05	6.20e-04	32|284|156|2762	PF00045;PF00097;PF00122;PF00149;PF00258;PF00383;PF00413;PF00557;PF00667;PF00675;PF00689;PF00690;PF00702;PF01033;PF01179;PF01302;PF01352;PF01421;PF01433;PF01471;PF01485;PF01562;PF02008;PF02148;PF04116;PF04389;PF05193;PF05485;PF06297;PF07258;PF13242;PF13920
Group	GO:0008237	metallopeptidase activity	2	4.47	1.93e-04	1.70e-03	12|284|37|2762	PF00040;PF00045;PF00090;PF00413;PF00557;PF00675;PF01400;PF01421;PF01471;PF01562;PF04389;PF05193
Group	GO:0016881	acid-amino acid ligase activity	2	4.09	2.19e-04	1.75e-03	22|284|97|2762	PF00097;PF00168;PF00179;PF00240;PF00400;PF00415;PF00515;PF00622;PF00651;PF01485;PF02214;PF02225;PF02891;PF03133;PF03256;PF05773;PF07707;PF12796;PF12906;PF13639;PF13920;PF14324
Group	GO:0042623	ATPase activity, coupled	2	3.87	3.80e-04	2.68e-03	24|284|114|2762	PF00063;PF00122;PF00270;PF00271;PF00373;PF00385;PF00622;PF00689;PF00690;PF00702;PF01496;PF01751;PF02518;PF04408;PF06079;PF06733;PF08393;PF12710;PF12774;PF12775;PF12780;PF13086;PF13246;PF13405
Group	GO:0003779	actin binding	2	3.95	5.19e-04	3.04e-03	15|284|58|2762	PF00063;PF00241;PF00307;PF00400;PF00435;PF00651;PF01044;PF02181;PF06367;PF06371;PF07651;PF07707;PF10409;PF12510;PF13405
Group	GO:0005516	calmodulin binding	2	4.03	5.64e-04	3.10e-03	12|284|41|2762	PF00063;PF00122;PF00130;PF00149;PF00168;PF00622;PF00689;PF00690;PF00702;PF01496;PF08232;PF13857
Group	GO:0038024	cargo receptor activity	2	4.54	6.07e-04	3.24e-03	6|284|12|2762	PF00057;PF01033;PF01391;PF02225;PF04389;PF07645
Group	GO:0005201	extracellular matrix structural constituent	2	4.27	1.03e-03	4.62e-03	6|284|13|2762	PF00053;PF00093;PF01391;PF02210;PF07645;PF13855
Group	GO:0003774	motor activity	2	3.93	9.28e-04	4.62e-03	10|284|32|2762	PF00063;PF00169;PF00373;PF07728;PF08393;PF09379;PF12774;PF12775;PF12780;PF13405
Group	GO:0001948	glycoprotein binding	2	4.01	1.32e-03	5.54e-03	7|284|18|2762	PF00093;PF00094;PF00307;PF01826;PF02210;PF07645;PF08742
Group	GO:0000988	protein binding transcription factor activity	2	3.37	1.55e-03	6.08e-03	23|284|118|2762	PF00076;PF00130;PF00168;PF00270;PF00271;PF00400;PF00622;PF00989;PF01448;PF01753;PF02148;PF02201;PF02891;PF03826;PF03920;PF06297;PF07531;PF08447;PF08711;PF11717;PF12874;PF13415;PF14324
Group	GO:0030507	spectrin binding	2	4.14	1.81e-03	6.93e-03	5|284|10|2762	PF00373;PF00435;PF08736;PF09379;PF09380
Group	GO:0004175	endopeptidase activity	2	3.44	1.85e-03	6.94e-03	15|284|65|2762	PF00040;PF00045;PF00057;PF00082;PF00413;PF00675;PF00754;PF01400;PF01471;PF01562;PF02148;PF02225;PF05193;PF08246;PF13405
Group	GO:0050839	cell adhesion molecule binding	2	3.57	2.30e-03	8.45e-03	9|284|30|2762	PF00041;PF00373;PF01044;PF02210;PF07653;PF07679;PF07686;PF09379;PF09380
Group	GO:0004674	protein serine/threonine kinase activity	2	3.39	2.57e-03	8.86e-03	12|284|48|2762	PF00027;PF00041;PF00130;PF00168;PF00169;PF00271;PF00780;PF01064;PF05773;PF07679;PF08515;PF08926
Group	GO:0005518	collagen binding	3	5.81	1.31e-05	1.65e-04	9|284|17|2762	PF00041;PF00093;PF00094;PF00754;PF01826;PF03165;PF07645;PF08742;PF13855
Group	GO:0008022	protein C-terminus binding	3	5.57	2.39e-05	2.63e-04	9|284|18|2762	PF00122;PF00515;PF00689;PF00690;PF00778;PF00899;PF07653;PF10600;PF10608
Group	GO:0051087	chaperone binding	3	6.03	2.63e-05	2.73e-04	6|284|8|2762	PF00085;PF00094;PF00226;PF00515;PF01826;PF08742
Group	GO:0005319	lipid transporter activity	3	4.58	3.11e-04	2.38e-03	8|284|19|2762	PF00122;PF00169;PF00501;PF00702;PF02121;PF03765;PF12710;PF13246
Group	GO:0042169	SH2 domain binding	3	4.84	3.32e-04	2.43e-03	6|284|11|2762	PF00041;PF00169;PF00400;PF00564;PF00757;PF01030
Group	GO:0005545	1-phosphatidylinositol binding	3	5.14	5.04e-04	3.04e-03	4|284|5|2762	PF00169;PF00435;PF07651;PF13716
Group	GO:0008143	poly(A) RNA binding	3	5.14	5.04e-04	3.04e-03	4|284|5|2762	PF00076;PF00270;PF00271;PF00622
Group	GO:0035255	ionotropic glutamate receptor binding	3	5.14	5.04e-04	3.04e-03	4|284|5|2762	PF07653;PF10600;PF10608;PF12796
Group	GO:0042731	PH domain binding	3	5.14	5.04e-04	3.04e-03	4|284|5|2762	PF00373;PF08736;PF09379;PF09380
Group	GO:0031072	heat shock protein binding	3	4.48	9.88e-04	4.62e-03	5|284|9|2762	PF00226;PF00254;PF00515;PF00989;PF08447
Group	GO:0043548	phosphatidylinositol 3-kinase binding	3	4.48	9.88e-04	4.62e-03	5|284|9|2762	PF00041;PF00169;PF00757;PF01030;PF07679
Group	GO:0030165	PDZ domain binding	3	4.04	9.98e-04	4.62e-03	8|284|22|2762	PF00122;PF00689;PF00690;PF00702;PF01392;PF07679;PF07686;PF10409
Group	GO:0043130	ubiquitin binding	3	4.04	9.98e-04	4.62e-03	8|284|22|2762	PF00179;PF00226;PF00240;PF00400;PF00564;PF00789;PF01485;PF02148
Group	GO:0005384	manganese ion transmembrane transporter activity	3	4.55	1.39e-03	5.56e-03	4|284|6|2762	PF00122;PF00689;PF00690;PF00702
Group	GO:0047485	protein N-terminus binding	3	4.55	1.39e-03	5.56e-03	4|284|6|2762	PF00094;PF00271;PF01826;PF08742
Group	GO:0030145	manganese ion binding	3	3.80	2.51e-03	8.86e-03	6|284|15|2762	PF00122;PF00149;PF00557;PF00689;PF00690;PF00702
Group	GO:0046332	SMAD binding	3	3.59	2.56e-03	8.86e-03	8|284|25|2762	PF00019;PF00093;PF00688;PF00778;PF01064;PF01391;PF03165;PF08515
Group	GO:0071814	protein-lipid complex binding	3	4.09	2.98e-03	9.90e-03	4|284|7|2762	PF00057;PF00082;PF01391;PF07645
Group	GO:0046625	sphingolipid binding	3	4.09	2.98e-03	9.90e-03	4|284|7|2762	PF00053;PF00169;PF01302;PF12796
Group	GO:0005086	ARF guanyl-nucleotide exchange factor activity	4	5.12	1.08e-03	4.62e-03	3|284|3|2762	PF01369;PF09324;PF12783
Group	GO:0034237	protein kinase A regulatory subunit binding	4	5.12	1.08e-03	4.62e-03	3|284|3|2762	PF01369;PF09324;PF12783
